Key result
Cathepsin K promotes stress-induced pulmonary hypertension in mice via smooth muscle phenotypic switching.
Why the study?
Chronic psychological stress is a risk factor for metabolic pulmonary artery hypertension, and the role of lysosomal cathepsin K in stress-related PAH via TGF-beta/TGF-betaR2-SMAD2/3 signaling-mediated phenotypic switching of pulmonary artery smooth muscle cells required investigation.
Does genetic deletion or silencing of cathepsin K attenuate right-ventricular systolic pressure elevation, pulmonary vascular remodeling, and PASMC phenotypic switching in a mouse model of chronic stress-related pulmonary arterial hypertension?
Does genetic deletion or silencing of cathepsin K attenuate right-ventricular systolic pressure elevation, pulmonary vascular remodeling, and PASMC phenotypic switching in a mouse model of chronic stress-related pulmonary arterial hypertension?
Cathepsin K is a critical driver of chronic stress-exacerbated pulmonary arterial hypertension in mice via a self-amplifying CTSK–TGF-β–SMAD2/3 signaling circuit that promotes PASMC phenotypic switching and proliferation.
Answers are grounded in this paper and cite their sources.
Cathepsin K inhibition merits testing in stress-related pulmonary hypertension; animal and single-cell data leave open clinical translation.
Aims Exposure to chronic psychological stress is a risk factor for metabolic pulmonary artery hypertension (PAH). Given the critical role of lysosomal cathepsin K (CTSK) in human pathobiology, we examined the role of CTSK in stress-related PAH, focusing on TGFβ/TGF-βR2-SMAD2/3 signaling-mediated switching of the phenotypical changes pf pulmonary artery smooth muscle cells (PASMCs). Methods and Results Eight-week-old male wild-type (CTSK +/+ ) and CTSK-knockout (CTSK −/− ) mice were subjected to hypoxia ± the tyrosine-kinase inhibitor SU-5416 with or without chronic restraint stress (CRS). Upon model establishment, the right-ventricular systolic pressure and vascular remodeling were quantified by echocardiography, micro-tip pressure sensor catheter, and biological and histomorphometry methods. Single-cell RNA sequencing (scRNA-seq) revealed elevated CTSK expression in PASMCs from idiopathic PAH patients. In mice, hypoxia ± SU-5416 induced CTSK expression and triggered PAH pathology that was markedly exacerbated by superimposed CRS. Genetic deletion of CTSK attenuated key features of PAH, including right-ventricular systolic pressure elevation and vascular remodeling, as well as a shift of PASMCs towards a synthetic phenotype characterized by increased expressions of extracellular-matrix genes (fibronectin, CTSK, and collagen I), a parallel induction of synthetic markers (TGF-β, VIM, and VCAN), and a decrease in contractile genes (SM22α, CNN1, and ATAC2). Mechanistically, CTSK formed a positive-feedback loop with TGF-β–SMAD2/3 signaling. In PASMCs, the silencing of CTSK abolished hypoxia- and stress-serum-induced cell proliferation and disrupted this loop, whereas CTSK overexpression amplified both. Conclusions These results identified CTSK as a critical contributor to PAH pathogenesis, particularly under chronic stress conditions. CTSK drives disease progression by enforcing a self-amplifying CTSK–TGF-β–SMAD2/3 circuit that switches PASMC phenotype change and proliferation.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied Chronic stress-related pulmonary hypertension. Cathepsin K (CTSK) knockout / modulation vs. Wild-type (CTSK+/+) / control was evaluated. Cathepsin K-mediated phenotypic switching of pulmonary artery smooth muscle contributed to chronic stress-related pulmonary hypertension in mice, though quantitative results are not in the text.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: